OIS@ASCRS

TearClear Delivering Preservative-Free Drugs Interview at OIS@ASCRS 2019

By OIS Contributor | October 9, 2019

Chairman Rick Heinick says TearClear will change the face of how drugs are delivered to patients. REGISTER for our next ophthalmology conference today. While there…

GenSight Biologics – Innovation Showcase at Ophthalmology Innovation Summit @ ASCRS 2019

By OIS Contributor | August 20, 2019

Barrett Katz, Chief Medical Officer speaks for GenSight Biologics during the Innovative Showcase at OIS@ASCRS 2019. REGISTER for our next ophthalmology conference today. Download Presentation…

Ocular Therapeutix – Innovation Showcase at Ophthalmology Innovation Summit @ ASCRS 2019

By OIS Contributor | August 14, 2019

Antony Mattessich, President & CEO speaks for Ocular Therapeutix during the Innovative Showcase at OIS@ASCRS 2019. REGISTER for our next ophthalmology conference today. Download Presentation…

Novartis Has a Wide-ranging Pipeline Interview at Ophthalmology Innovation Summit @ ASCRS 2019

By OIS Contributor | August 14, 2019

Jehan Tamboowalla, vice president, head of new products, ophthalmology, Novartis, says they have an amazing pipeline that covers 4 key areas—retina, rare disease, regenerative medicine,…

Mati Therapeutics | Bob Butchofsky, CEO - OIS@ASCRS - 2019

Mati’s Versatile Punctal Delivery System

By Healthegy Admin | August 7, 2019

From the OIS@ASCRS podium, Mati Therapeutics’ Bob Butchofsky provides an update on the Evolute punctal plug delivery system, which is being developed to deliver multiple…

Johnson & Johnson Shows Up In a Meaningful Way

By Healthegy Admin | August 7, 2019

Tom Frinzi, worldwide president, surgical, talks about the importance of innovation and says J&J has a long history of it, including earlier this year launching…

Ocuphire Pharma | Mina Sooch, President & CEO

By Healthegy Admin | July 31, 2019

Ocuphire Pharma | Mina Sooch, President & CEO

Olympic’s ‘Game-Changing’ Dry Eye Device

By Evan Munoz | July 23, 2019

Michael Gertner, Olympic Ophthalmics CEO, describes the company’s iTEAR neuromodulation device for dry eye as “a game changer” in this video from OIS@ASCRS. He also…

Nicox’s Big Bet on Nitric-Oxide Platform

By OIS Contributor | July 17, 2019

Nicox SA CEO and chairman Michele Garufi describes the company’s glaucoma-focused pipeline, drawing on its nitric-oxide platform. He explains how NO works in animal models…

Alcon Utilizes Internal, External Skill Sets

By OIS Contributor | July 17, 2019

Laurent Attias, SVP of freshly spun-off Alcon, talks up an agnostic approach to innovation in this interview with OIS TV’s Ehsan Sadri, MD, adding the…